Russell Investments Group’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.59M Buy
271,668
+42,442
+19% +$330K ﹤0.01% 1727
2025
Q4
$1.79M Sell
229,226
-85,267
-27% -$616K ﹤0.01% 1934
2025
Q3
$2.39M Sell
314,493
-125,756
-29% -$1.05M ﹤0.01% 1765
2025
Q2
$3.94M Buy
440,249
+336,920
+326% +$3.14M 0.01% 1358
2025
Q1
$775K Buy
103,329
+75,363
+269% +$608K ﹤0.01% 2139
2024
Q4
$210K Buy
27,966
+12,941
+86% +$98.2K ﹤0.01% 2528
2024
Q3
$114K Sell
15,025
-68,228
-82% -$519K ﹤0.01% 2629
2024
Q2
$515K Buy
83,253
+24,528
+42% +$135K ﹤0.01% 2187
2024
Q1
$298K Buy
58,725
+39,205
+201% +$220K ﹤0.01% 2362
2023
Q4
$117K Sell
19,520
-1,239
-6% -$7.18K ﹤0.01% 2531
2023
Q3
$147K Sell
20,759
-27,921
-57% -$201K ﹤0.01% 2546
2023
Q2
$343K Sell
48,680
-123,485
-72% -$991K ﹤0.01% 2339
2023
Q1
$1.44M Buy
172,165
+21,172
+14% +$204K ﹤0.01% 1771
2022
Q4
$1.73M Buy
150,993
+23,818
+19% +$297K ﹤0.01% 1682
2022
Q3
$1.6M Sell
127,175
-120,347
-49% -$1.55M ﹤0.01% 1673
2022
Q2
$2.62M Buy
247,522
+167,096
+208% +$1.72M 0.01% 1441
2022
Q1
$1.31M Buy
80,426
+78,363
+3,798% +$1.26M ﹤0.01% 1832
2021
Q4
$28K Hold
2,063
﹤0.01% 2935
2021
Q3
$29K Buy
+2,063
New +$32.5K ﹤0.01% 2977
2020
Q2
Sell
-161,807
Closed -$323K 3127
2020
Q1
$323K Sell
161,807
-172,918
-52% -$476K ﹤0.01% 2361
2019
Q4
$1.15M Buy
334,725
+172,180
+106% +$433K ﹤0.01% 2034
2019
Q3
$466K Buy
+162,545
New +$506K ﹤0.01% 2317
2017
Q3
Sell
-13,373
Closed -$74K 2944
2017
Q2
$74K Sell
13,373
-36,265
-73% -$221K ﹤0.01% 2839
2017
Q1
$417K Buy
49,638
+33,438
+206% +$233K ﹤0.01% 2490
2016
Q4
$104K Buy
+16,200
New +$84.3K ﹤0.01% 2864

Other funds holding BCRX